Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia
Open accessThe DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Abstract
In subjects with schizophrenia, impairments in working memory are associated with dysfunction of the dorsolateral prefrontal cortex (DLPFC). This dysfunction appears to be due, at least in part, to abnormalities in gamma-aminobutyric acid (GABA)-mediated inhibitory circuitry. To test the hypothesis that altered GABA-mediated circuitry in the DLPFC of subjects with schizophrenia reflects expression changes of genes that encode selective presynaptic and postsynaptic components of GABA neurotransmission, we conducted a systematic expression analysis of GABA-related transcripts in the DLPFC of 14 pairs of schizophrenia and age-, sex- and post-mortem interval-matched control subjects using a customized DNA microarray with enhanced sensitivity and specificity. Subjects with schizophrenia exhibited expression deficits in GABA-related transcripts encoding (1) presynaptic regulators of GABA neurotransmission (67 kDa isoform of glutamic acid decarboxylase (GAD(67)) and GABA transporter 1), (2) neuropeptides (somatostatin (SST), neuropeptide Y (NPY) and cholecystokinin (CCK)) and (3) GABA(A) receptor subunits (alpha1, alpha4, beta3, gamma2 and delta). Real-time qPCR and/or in situ hybridization confirmed the deficits for six representative transcripts tested in the same pairs and in an extended cohort, respectively. In contrast, GAD(67), SST and alpha1 subunit mRNA levels, as assessed by in situ hybridization, were not altered in the DLPFC of monkeys chronically exposed to antipsychotic medications. These findings suggest that schizophrenia is associated with alterations in inhibitory inputs from SST/NPY-containing and CCK-containing subpopulations of GABA neurons and in the signaling via certain GABA(A) receptors that mediate synaptic (phasic) or extrasynaptic (tonic) inhibition. In concert with previous findings, these data suggest that working memory dysfunction in schizophrenia is mediated by altered GABA neurotransmission in certain DLPFC microcircuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an expression analysis of DLPFC from SZ patients indicated the reduced expression of several GABA-related genes, including neuropeptides and both presynaptic and postsynaptic markers 183.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [183]
In the citing paper
“Despite variable results, consistent findings across studies can be identified, including dysregulation of GABAergic signalling102; downregulation of oligodendrocyte- and myelination-related genes103, mitochondrial function or energy metabolism104, and synaptic genes105; and upregulation of immune and inflammatory genes106.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [102]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,907
Conflict monitoring and cognitive control
Botvinick, M. M., Braver, T. S., Barch, D. M., Carter, C. S., & Cohen, J. D. (2001) · Psychological Review · doi:10.1037/0033-295x.108.3.624 · Cited by 7,351
Applied Linear Statistical Models
(1997) · Technometrics · doi:10.1080/00401706.1997.10485141 · Cited by 7,185
Neurophysiological investigation of the basis of the fMRI signal
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001) · Nature · doi:10.1038/35084005 · Cited by 6,551
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Research works printed but not linked: 2
- Melchitzky DS, Lewis DA . Synaptic targets of somatostatin-labeled axon terminals in monkey prefrontal cortex. Soc Neurosci Abstr 2005; 675: 6.
- Kim AM, Matzilevich DA, Walsh JP, Benes FM, Woo TW . Parvalbumin-containing neurons and disturbances of prefrontal cortical circuitry in schizophrenia. Soc Neurosci Abstr 2005; 912: 1.
Cited by
Items 201–300 of 503
Grent-‘t-Jong, T., Rivolta, D., Sauer, A., Grube, M., Singer, W., Wibral, M., & Uhlhaas, P. J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.003 · Cited by 52
Alterations of perineuronal nets in the dorsolateral prefrontal cortex of neuropsychiatric patients
Alcaide, J., Guirado, R., Crespo, C., Blasco-Ibáñez, J. M., Varea, E., Sanjuan, J., & Nacher, J. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0161-0 · Cited by 51
Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain
Mueller, T., Remedies, C. E., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.102 · Cited by 50
Mullin, A. P., Sadanandappa, M. K., Ma, W., Dickman, D. K., VijayRaghavan, K., Ramaswami, M., Sanyal, S., & Faúndez, V. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3542-14.2015 · Cited by 50
Recent advances in postmortem pathology and neurochemistry in schizophrenia
Dean, B., Boer, S., Gibbons, A., Money, T., & Scarr, E. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328323d52e · Cited by 51
Machine learning in schizophrenia genomics, a case‐control study using 5,090 exomes
Trakadis, Y. J., Sardaar, S., Chen, A., Fulginiti, V., & Krishnan, A. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32638 · Cited by 53
Kim, P., Scott, M. R., & Meador‐Woodruff, J. H. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0537-7 · Cited by 50
Gonzalez-Burgos, G., Rotaru, D. C., Zaitsev, A. V., Povysheva, N. V., & Lewis, D. A. (2009) · Journal of Neurophysiology · doi:10.1152/jn.91161.2008 · Cited by 48
Self-citationMicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
Zhang, H.-C., Du, Y., Chen, L., Yuan, Z., & Cheng, Y. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105064 · Cited by 50
Beneyto, M., Morris, H. M., Rovensky, K. C., & Lewis, D. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.029 · Cited by 43
Self-citationReductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia
Purves-Tyson, T. D., Brown, A. M., Weissleder, C., Rothmond, D. A., & Weickert, C. S. (2021) · Molecular Brain · doi:10.1186/s13041-021-00805-7 · Cited by 53
Struyf, J., Dobrin, S. E., & Page, D. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-531 · Cited by 51
Fillman, S. G., Duncan, C. E., Webster, M. J., Elashoff, M., & Weickert, C. S. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.05.004 · Cited by 45
Centanni, S. W., Burnett, E. J., Trantham‐Davidson, H., & Chandler, L. J. (2017) · Addiction Biology · doi:10.1111/adb.12353 · Cited by 44
Schoonover, K. E., Dienel, S. J., & Lewis, D. A. (2020) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2020.100015 · Cited by 51
Self-citationDamgaard, T., Plath, N., Neill, J. C., & Hansen, S. L. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2039-9 · Cited by 47
Scarr, E., Udawela, M., & Dean, B. (2018) · Schizophrenia · doi:10.1038/s41537-018-0044-x · Cited by 50
Fatemi, S. H., Folsom, T. D., & THURAS, P. D. (2017) · Synapse · doi:10.1002/syn.21973 · Cited by 49
Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology
Catts, V. S., & Shannon Weickert, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035511 · Cited by 43
Gavin, D. P., & Akbarian, S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.008 · Cited by 44
Luoni, A., Hulsken, S., Cazzaniga, G., Racagni, G., Homberg, J. R., & Riva, M. A. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001332 · Cited by 43
Roshan‐Milani, S., Seyyedabadi, B., Saboory, E., Parsamanesh, N., & Mehranfard, N. (2021) · Stress · doi:10.1080/10253890.2021.1942828 · Cited by 45
Weber‐Stadlbauer, U., Langhans, W., & Meyer, U. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.146 · Cited by 45
Elser, B. A., Kayali, K., Dhakal, R., O’Hare, B., Wang, K., Lehmler, H., & Stevens, H. E. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa040 · Cited by 47
Fish, K. N., Rocco, B. R., DeDionisio, A. M., Dienel, S. J., Sweet, R. A., & Lewis, D. A. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.009 · Cited by 43
Self-citationGABA-Synthesizing Enzymes in Calbindin and Calretinin Neurons in Monkey Prefrontal Cortex
Rocco, B. R., Sweet, R. A., Lewis, D. A., & Fish, K. N. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv051 · Cited by 44
Self-citationNomura, T., Oyamada, Y., Fernandes, H. B., Remmers, C. L., Xu, J., Meltzer, H. Y., & Contractor, A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.012 · Cited by 42
Progress in defining the biological causes of schizophrenia
Pickard, B. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001955 · Cited by 47
Eagleson, K. L., Gravielle, M. C., Schlueter McFadyen-Ketchum, L. J., Russek, S. J., Farb, D. H., & Levitt, P. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.066 · Cited by 40
Richetto, J., Labouesse, M. A., Poe, M. M., Cook, J. M., Grace, A. A., Riva, M. A., & Meyer, U. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu055 · Cited by 42
Maksymetz, J., Byun, N. E., Luessen, D. J., Li, B., Barry, R. L., Gore, J. C., Niswender, C. M., Lindsley, C. W., Joffe, M. E., & Conn, P. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109950 · Cited by 41
Hines, R. M., Hines, D. J., Houston, C. M., Mukherjee, J. T., Haydon, P. G., Tretter, V. E., Smart, T. G., & Moss, S. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308706110 · Cited by 41
Alterations in a Unique Class of Cortical Chandelier Cell Axon Cartridges in Schizophrenia
Rocco, B. R., DeDionisio, A. M., Lewis, D. A., & Fish, K. N. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.018 · Cited by 42
Self-citationPharmacological Strategies for Enhancing Cognition in Schizophrenia
Barch, D. M. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_39 · Cited by 42
High White Matter Neuron Density with Elevated Cortical Cytokine Expression in Schizophrenia
Fung, S. J., Joshi, D., Fillman, S. G., & Weickert, C. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.031 · Cited by 40
Chronic reduction in inhibition reduces receptive field size in mouse auditory cortex
Seybold, B. A., Stanco, A., Cho, K. K. A., Potter, G. B., Kim, C., Sohal, V. S., Rubenstein, J. L. R., & Schreiner, C. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205909109 · Cited by 38
An updated overview of animal models in neuropsychiatry
Razafsha, M., Behforuzi, H., Harati, H., Wafai, R. A., Khaku, A. S., Mondello, S., Gold, M. S., & Kobeissy, F. H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.045 · Cited by 44
Garbett, K. A., Gal-Chis, R., Gaszner, G., Lewis, D. A., & Mirnics, K. (2008) · PubMed · Cited by 37
Self-citationSex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia
Bristow, G. C., Bostrom, J., Haroutunian, V. H., & Sodhi, M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.025 · Cited by 41
Buzhdygan, T. P., Lisinicchia, J. G., Patel, V., Johnson, K., Neugebauer, V., Paessler, S., Jennings, K., & Gelman, B. B. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9652-2 · Cited by 38
Bristow, G. C., Thomson, D. M., Openshaw, R. L., Mitchell, E. J., Pratt, J. A., Dawson, N., & Morris, B. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107536 · Cited by 36
“Reduced parvalbumin (Pvalb), calbindin, and somatostatin (SST) expression in regions of the PFC and orbitofrontal cortex (OFC) are arguably the most robust neurochemical abnormality detected in post-mortem tissue from patients with SZ (Hashimoto et al., 2008; Hoftman et al., 2015).”
BackgroundPositron emission tomography imaging of the γ-aminobutyric acid system
Andersson, J. D., Matuskey, D., & Finnema, S. J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.08.010 · Cited by 39
ErbB4 reduces synaptic GABA A currents independent of its receptor tyrosine kinase activity
Mitchell, R. M., Janssen, M. J., Karavanova, I. D., Vullhorst, D., Furth, K. E., Makusky, A. J., Markey, S. P., & Buonanno, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312791110 · Cited by 38
Dysfunctional role of parietal lobe during self-face recognition in schizophrenia
Yun, J., Hur, J., Jung, W. H., Jang, J. H., Youn, T., Kang, D., Park, S., & Kwon, J. S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.010 · Cited by 36
Neural substrates underlying delusions in schizophrenia
Zhu, J., Zhuo, C., Liu, F., Xu, L., & Yu, C. (2016) · Scientific Reports · doi:10.1038/srep33857 · Cited by 38
Cuypers, K., Hehl, M., van Aalst, J., Chalavi, S., Mikkelsen, M. E., Laere, K. V., Dupont, P. J., Mantini, D., & Swinnen, S. P. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117536 · Cited by 41
Modulation of behavioral networks by selective interneuronal inactivation
Schmidt, M. J., Horvath, S., Ebert, P., Norris, J. L., Seeley, E. H., Brown, J., Gellert, L., Everheart, M., Garbett, K. A., Grice, T. W., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.167 · Cited by 35
Self-citationAlshammari, T. K., Alshammari, M. A., Nenov, M. N., Hoxha, E., Cambiaghi, M., Marcinnò, A., James, T. F., Singh, P. K., Labate, D., Li, J., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.66 · Cited by 35
Challenges and opportunities for the development of new antipsychotic drugs
Forray, C., & Buller, R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.05.009 · Cited by 39
Lis, M., Stańczykiewicz, B., Liśkiewicz, P., & Misiak, B. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104744 · Cited by 35
Arun, P., Madhavarao, C. N., Moffett, J. R., & Namboodiri, A. M. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05524.x · Cited by 38
Tenorio, J. A., Alarcón, P., Arias, P., Dapía, I., García‐Miñáur, S., Palomares‐Bralo, M., Campistol, J., Climent, S., Valenzuela, I., Ramos, S., et al. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0485-3 · Cited by 35
Mapping synaptic pathology within cerebral cortical circuits in subjects with schizophrenia
Sweet, R. A., Fish, K. N., & Lewis, D. A. (2010) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2010.00044 · Cited by 41
Lin, C.-Y., Sawa, A., & Jaaro-Peled, H. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.025 · Cited by 37
Using human brain imaging studies as a guide toward animal models of schizophrenia
Bolkan, S. S., Poyraz, F. C., & Kellendonk, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.055 · Cited by 34
Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin
Turner, C. P., DeBenedetto, D., Ware, E., Stowe, R. C., Lee, A. J., Swanson, J. M., Walburg, C., Lambert, A., Lyle, M. A., Desai, P., et al. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-2059-z · Cited by 36
The Role of Redox Dysregulation in the Effects of Prenatal Stress on Embryonic Interneuron Migration
Bittle, J., Menezes, E. D. C., McCormick, M. L., Spitz, D. R., Dailey, M. E., & Stevens, H. E. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz052 · Cited by 41
Risk genes for schizophrenia: Translational opportunities for drug discovery
Winchester, C. L., Pratt, J. A., & Morris, B. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.003 · Cited by 34
Synapse-specific contributions in the cortical pathology of schizophrenia
Seshadri, S., Zeledon, M., & Sawa, A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.009 · Cited by 31
Georgiev, D., González-Burgos, G., Kikuchi, M., Minabe, Y., Lewis, D. A., & Hashimoto, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043904 · Cited by 33
Self-citationDuchatel, R. J., Jobling, P., Graham, B. A., Harms, L. R., Michie, P. T., Hodgson, D. M., & Tooney, P. A. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.09.006 · Cited by 34
Alherz, F. A., Alherz, M., & Almusawi, H. M. (2017) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2017.02.001 · Cited by 37
Sommer, J. U., Schmitt, A., Heck, M., Schaeffer, E. L., Fendt, M., Zink, M., Nieselt, K., Symons, S., Petroianu, G. A., Lex, A., et al. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0159-1 · Cited by 32
Gillespie, B., Panthi, S., Sundram, S., & Hill, R. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105488 · Cited by 33
Turning the ′Tides on Neuropsychiatric Diseases: The Role of Peptides in the Prefrontal Cortex
Brockway, D. F., & Crowley, N. A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.588400 · Cited by 33
Fung, S. J., Webster, M. J., & Weickert, C. S. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.004 · Cited by 33
Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders
Archer, T., Beninger, R. J., Palomo, T., & Kostrzewa, R. M. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9163-5 · Cited by 31
Etemadikhah, M., Niazi, A., Wetterberg, L., & Feuk, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-57467-z · Cited by 31
Wearne, T. A., & Cornish, J. L. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109681 · Cited by 31
Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis
Ballaz, S., & Bourin, M. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666201113145143 · Cited by 30
Murueta‐Goyena, A., Ortuzar, N., Gargiulo, P. Á., Lafuente, J. V., & Bengoetxea, H. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0715-z · Cited by 31
Weissleder, C., Webster, M. J., Barry, G., & Weickert, C. S. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa159 · Cited by 31
Guerra, A., Rocchi, L., Grego, A., Berardi, F., Luisi, C., & Ferreri, F. (2021) · Brain Sciences · doi:10.3390/brainsci11030405 · Cited by 29
Imprecise Predictive Coding Is at the Core of Classical Schizophrenia
Liddle, P. F., & Liddle, E. B. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.818711 · Cited by 34
Epigenetic Profiling in Schizophrenia and Major Mental Disorders
Iwamoto, K., & Kato, T. (2009) · Neuropsychobiology · doi:10.1159/000234811 · Cited by 28
Ginsberg, S. D., Hemby, S. E., & Smiley, J. F. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.015 · Cited by 30
Joshi, D., Catts, V. S., Olaya, J. C., & Weickert, C. S. (2015) · Schizophrenia · doi:10.1038/npjschz.2014.4 · Cited by 33
Chang, C., Chen, Y.-W., Wang, T., & Lai, W. (2016) · Scientific Reports · doi:10.1038/srep33095 · Cited by 29
Garbett, K. A., Horváth, S., Ebert, P. J., Schmidt, M. J., Lwin, K.-O., Mitchell, A., Levitt, P. R., & Mirnics, K. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.1 · Cited by 27
Self-citationAbnormal GABAergic Function and Negative Affect in Schizophrenia
Taylor, S. F., Demeter, E., Phan, K. L., Tso, I. F., & Welsh, R. C. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.300 · Cited by 28
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Antagonists: From Bench to Bedside
Mattes, H., Carcache, D. A., Kalkman, H. O., & Koller, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901688m · Cited by 29
Fujihara, K., Yamada, K., Ichitani, Y., Kakizaki, T., Jiang, W., Miyata, S., Suto, T., Kato, D., Saito, S., Watanabe, M., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01108-6 · Cited by 33
Morris, H. M., Stopczynski, R. E., & Lewis, D. A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.09.014 · Cited by 32
Self-citationMurano, T., Hagihara, H., Tajinda, K., Matsumoto, M., & Miyakawa, T. (2019) · Communications Biology · doi:10.1038/s42003-018-0277-2 · Cited by 30
Neuropathology of Schizophrenia
Harrison, P. J., Lewis, D. A., & Kleinman, J. E. (2010) · Schizophrenia · doi:10.1002/9781444327298.ch18 · Cited by 26
Self-citationBaek, H., Yi, M., Pandit, S., Park, J. B., Kwon, H. H., Zhang, E., Kim, S., Shin, N., Kim, E., Lee, Y., et al. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.05.006 · Cited by 29
Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia
Zhang, Y., Catts, V. S., & Weickert, C. S. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417728805 · Cited by 27
Jami, S. A., Cameron, S., Wong, J. M., Daly, E. R., McAllister, A. K., & Gray, J. A. (2021) · Journal of Neurophysiology · doi:10.1152/jn.00661.2020 · Cited by 27
Dienel, S. J., Dowling, K. F., Barile, Z. J., Bazmi, H. H., Liu, A. Y., Vespoli, J. C., Fish, K. N., & Lewis, D. A. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.2972 · Cited by 28
Self-citationActivation of GABAA receptors in the medial prefrontal cortex produces an anxiolytic-like response
Solati, J., Hajikhani, R., & Golub, Y. (2012) · Acta Neuropsychiatrica · doi:10.1111/acn.12016 · Cited by 30
Bissonette, G. B., Bae, M. H., Suresh, T., Jaffe, D. E., & Powell, E. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5268-09.2010 · Cited by 27
Schlicker, E., & Feuerstein, T. J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.005 · Cited by 25
Adorján, I., Sun, B., Feher, V., Tyler, T., Veres, D. S., Chance, S. A., & Szele, F. G. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.581685 · Cited by 25
Park, D. K., Petshow, S., Anisimova, M., Barragan, E. V., Gray, J. A., Stein, I. S., & Zito, K. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105772 · Cited by 25
Global knockdown of glutamate decarboxylase 67 elicits emotional abnormality in mice
Miyata, S., Kakizaki, T., Fujihara, K., Obinata, H., Hirano, T., Nakai, J., Tanaka, M., Itohara, S., Watanabe, M., Tanaka, K. F., et al. (2021) · Molecular Brain · doi:10.1186/s13041-020-00713-2 · Cited by 25
Long, L. E., Anderson, P., Frank, E., Shaw, A. D., Liu, S., Huang, X., Pinault, D., Karl, T., O'Brien, T. J., Weickert, C. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124114 · Cited by 27
Pathogenic Mis-splicing of CPEB4 in Schizophrenia
Ollà, I., Pardiñas, A. F., Parras, A., Hernández, I. H., Santos‐Galindo, M., Picó, S., Callado, L. F., Elorza, A., Rodríguez-López, C., Fernández‐Miranda, G., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.03.010 · Cited by 23
Logotheti, M., Papadodima, O., Venizelos, N., Chatziioannou, A. A., & Kolisis, F. N. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/685917 · Cited by 23
Temporal dysregulation of cortical gene expression in the isolation reared Wistar rat
Murphy, K. J., ter Horst, J. P., Cassidy, A. W., DeSouza, I. E. J., Morgunova, M., Li, C., Connole, L. M., O’Sullivan, N. C., Loscher, J. S., Brady, A. T., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06617.x · Cited by 28
Neonatal allopregnanolone levels alteration: Effects on behavior and role of the hippocampus
Darbra, S., Mòdol, L., Llidó, A., Casas, C., Vallée, M., & Pallarés, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.07.007 · Cited by 29
Metadata
- Authors
- Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Lewis, D A
- Venue
- Molecular Psychiatry
- Published
- 2007-05-01
- Volume
- 13
- Issue
- 2
- Pages
- 147-161
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2882638
- OpenAlex
- W2126843605
- Cited by
- 490
- References
- 262
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 17 · 2023: 17 · 2022: 15 · 2021: 24 · 2020: 29 · 2019: 22 · 2018: 26 · 2017: 25 · 2016: 33 · 2015: 42 · 2014: 25 · 2013: 29 · 2012: 27
- FWCI
- 20.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Eli Lilly and Company
- National Institutes of Health
- Medical Center, University of Pittsburgh
- National Institute of Mental Health (R01MH043784, MH43784, MH 45156, MH-067234, MH070786, K02MH070786, R01MH067234, P50MH045156, R37MH043784)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD015052)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, dorsolateral prefrontal cortex, GABAergic neurotransmission, gene expression, working memory, GAD67, GABA transporter 1, somatostatin, neuropeptide Y, cholecystokinin, GABAA receptor subunits, presynaptic inhibition, tonic inhibition, antipsychotic exposure, inhibitory interneurons
- MeSH terms
- Olanzapine, Adult, Aged, Animals, Benzodiazepines, Chloroquinolinols, Female, Gene Expression Regulation, Glutamate Decarboxylase, Humans, Macaca fascicularis, Male, Middle Aged, Neuropeptides, Receptors, GABA-A, Schizophrenia, Antipsychotic Agents, Case-Control Studies, Prefrontal Cortex, Oligonucleotide Array Sequence Analysis, Protein Subunits, GABA Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.